In this section, the proposed method was evaluated using gene expression data (p53 cell lines, colon cancer and breast cancer) and the Molecular Signatures Database (MSigDB) [20, 21] gene sets which are widely used [1, 15, 22–25]. The gene discussed is TP53; the disease is breast cancer.